Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Submitted by
admin
on July 30, 2016 - 9:53pm
Source:
Market Realist
News Tags:
Amgen
Prolia
Xgeva
osteoporosis
Headline:
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Do Not Allow Advertisers to Use My Personal information
